Business Wire

Patient Safety Movement Foundation Announces Winners of 2020 Humanitarian Awards

10.2.2021 16:00:00 EET | Business Wire | Press release

Share

The Patient Safety Movement Foundation (PSMF), a global non-profit committed to achieving zero preventable patient deaths by 2030, announced the winners of its 2020 Humanitarian Awards at a virtual ceremony on February 8, 2021. The recipients included Steve Burrows, Vonda Vaden Bates, Marty Hatlie and Barb Pelletreau. Each year the Humanitarian Awards recognize leaders who have made significant progress in the last year eliminating or raising awareness of preventable patient deaths.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210210005339/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Steve Burrows, Vonda Vaden Bates, Marty Hatlie and Barb Pelletreau were recognized by the Patient Safety Movement Foundation for their efforts eliminating and raising awareness of preventable patient deaths (Photo: Business Wire)

“To achieve our goal of zero preventable patient deaths by 2030, it is critical to unify people and collectively improve patient safety across the globe,” said David B. Mayer, MD, CEO of Patient Safety Movement Foundation. “We are pleased to honor each of these individuals for their remarkable efforts to spread public awareness of this important issue and improve the patient experience for everyone.”

The Humanitarian Award recipients were honored across three categories this year – the Judie Burrows award, Michael Seres award and Steven Moreau award. The Judie Burrows award was established to recognize an individual who has told a story of preventable harm or death that has made a significant impact in the public sphere in the last year. The Michael Seres award was designed in honor of lifelong patient safety advocate, Michael Seres, who passed away in May 2020. This award recognizes an individual who contributed to the advancement of person and family engagement, public awareness and public engagement in patient safety. The Steven Moreau award is given to a hospital administrator who possesses a zeal for improving patient safety at their hospital. This year’s recipients included:

  • Steve Burrows, writer and director of the acclaimed documentary “Bleed Out,” was recognized with the Judie Burrows award for the impact his HBO film had in elevating the issues around patient safety in the public domain. His documentary follows the story of his mother, Judie Burrows, who experienced a preventable medical error during a partial hip surgery that afflicted her for the rest of her life. Since “Bleed Out” was released in December 2018 over 10 million viewers have watched the film on HBO. Prior to its release, Burrows, his wife Margo and their family thought they were alone, but within the first 24 hours of the film streaming they were inundated with thousands of Facebook messages from strangers who connected with Judie Burrows’ story.
  • Vonda Vaden Bates has been passionate about advancing public awareness and engagement around the issue of preventable hospital deaths since losing her husband, Charles “Yogiraj” Bates II, to a preventable venous thromboembolism in 2012. She played an integral role in the conceptualization and success of the #uniteforsafecare campaign – a collaborative effort between the Patient Safety Movement Foundation, American Society of Anesthesiologists (ASA), The Leapfrog Group and International Society for Quality in Health Care (ISQua) to bring attention to system-wide improvements that will ensure better health worker and patient safety outcomes. Bates was recognized with the Michael Seres award for her efforts to advance public awareness and for helping make the #uniteforsafecare campaign and PSMF-hosted events in September 2020 a success.
  • Marty Hatlie was also honored with the Michael Seres award. Hatlie has been a lifelong leader in patient safety since he served as executive director of the National Patient Safety Foundation. However, this humanitarian award acknowledges his exemplary work in the last 12 months. Hatlie served as one of the co-chairs for the March for Patient Safety turned #uniteforsafecare campaign. He dedicated much of 2019 and 2020 to launching the initiative.
  • Barb Pelletreau, senior vice president of patient safety at CommonSpirit Health (formally known as Dignity Health), received the Steven Moreau award. Pelletreau was recognized for her leadership of the now 150+ hospital system, where she leads patient safety improvement efforts with transparency and candor. Under her leadership, Dignity Health became a PSMF 5-star hospital for making commitments in alignment with the Patient Safety Movement Foundation’s evidence-based Actionable Patient Safety Solutions (APSS) last year, reaffirming its dedication and commitment to zero preventable deaths.

The Patient Safety Movement Foundation launched the Humanitarian Awards in 2013 to recognize individuals whose work helps advance patient safety. To learn more about the awards and past winners, visit: https://patientsafetymovement.org.

To watch the award presentation, visit https://patient.sm/Humanitarian-Awards.

About the Patient Safety Movement Foundation: Each year, more than 200,000 people die unnecessarily in U.S. hospitals. Worldwide, 4.8 million lives are similarly lost. The Patient Safety Movement Foundation (PSMF) is a global non-profit on a mission to eliminate preventable deaths from hospital errors. PSMF uniquely brings patients and patient advocates, healthcare providers, medical technology companies, government, employers and private payers together under the same cause. From its Actionable Patient Safety Solutions and industry Open Data Pledge to its World Patient Safety, Science & Technology Summit and more, PSMF won’t stop fighting until it achieves zero. For more information, please visit patientsafetymovement.org to learn more, and follow PSMF on LinkedIn, Twitter, Instagram and Facebook.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Leslie Licano, Beyond Fifteen Communications, Inc.
psmf@beyondfifteen.com | (949) 733-8679 ext.101

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development

Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye